Theravance Biopharma, Inc. capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.25x
Net debt / equity: -0.74x
Debt / assets: 0.16x
Debt / EBITDA: 0.51x
Net debt / EBITDA: -1.51x

Liquidity & coverage

Current ratio: 13.14x
Quick ratio: 13.14x
Cash ratio: 12.42x
Interest coverage: 0.05x
EBITDA / interest: 78.34x
Working capital: $385.9M

Cash & dividend

FCF / debt: 3.67x
Cash flow / debt: 3.67x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.